Clinical Trial

Pharmacokinetic Study of Eicosapentaenoic Acid (EPA) and Calcium L-5-Methyltetrahydrofolate (L-5-MTHF) After Administration of CreNeuroS® CNS Fish Oil Plus Softgels in Healthy Subjects Under Fasting Conditions

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 16, 2026 (before its estimated April 23, 2026 completion). Its status may not reflect the trial's current state.
Summary
Demographic data, medical and medication history, physical examination, 12-lead ECG, haematology, biochemistry, serology, urine routine analysis, additionally for females serum pregnancy test, hormone assay (FSH) will be done within 21 days and a chest X-ray within 06 months prior to check-in. In study period, each group subjects will be housed in the clinical facility for at least -60.00 hours pre-dose to 72.00 hours post-dose.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-03-06.
Trial Details
NCT Number NCT07461649
Lead Sponsor Sichuan Credit Pharmaceutical Co., Ltd.
Conditions Bioavailability and Pharmacokinetics
Enrollment 32 participants
Start Date 2026-03-15
Primary Completion 2026-04-23 (estimated)
Study Completion 2026-05-10 (estimated)
Updated on ClinicalTrials.gov 2026-03-16